Markus Reitzig

TL;DR: In this paper, the authors argue that even when there may be little that existing theory cannot explain about individual elements in these new forms of organizing, opportunities for new theorizing lie in understanding the bundles of cooccurring elements that seem to underlie them and why the same bundles occur in widely disparate organizations.

TL;DR: The authors analyzed the determinants of opposition to biotechnology and pharmaceutical patents granted by the European Patent Office between 1978-96 and showed that valuable patents are more likely to be attacked and that opposition is particularly frequent in areas with strong cumulative patent numbers and with high technical or market uncertainty.

TL;DR: The results show that accelerated examination requests and qualified word counts enhance the quality of existing valuation methods, as well as the validity of so-far untested indicators of patent value.

TL;DR: The authors analyzed the determinants of opposition to biotechnology and pharmaceutical patents granted by the European Patent Office (EPO) between 1978 and 1996 and found that 8.6% of the patents are attacked in opposition proceedings.

TL;DR: In this article, 127 individual patents from a semiconductor company were evaluated comprehensively by technical and marketing representatives, and the analysis of this rare data shows that for patents used as bargaining chips, novelty and inventive activity are most important.